Dilaveris Polychronis E, Antoniou Christos Konstantinos, Caiani Enrico G, Casado-Arroyo Ruben, Climent Andreu Μ, Cluitmans Matthijs, Cowie Martin R, Doehner Wolfram, Guerra Federico, Jensen Magnus T, Kalarus Zbigniew, Locati Emanuela Teresa, Platonov Pyotr, Simova Iana, Schnabel Renate B, Schuuring Mark, Tsivgoulis Georgios, Lumens Joost
First Department of Cardiology, Hippokration Hospital, National and Kapodistrian University of Athens, 114 Vas. Sofias Avenue, 11527 Athens, Greece.
Electrophysiology and Pacing Laboratory, Athens Heart Centre, Athens Medical Center, Marousi, Attica, Greece.
Eur Heart J Digit Health. 2022 Jun 8;3(3):341-358. doi: 10.1093/ehjdh/ztac026. eCollection 2022 Sep.
The role of subclinical atrial fibrillation as a cause of cryptogenic stroke is unambiguously established. Long-term electrocardiogram (ECG) monitoring remains the sole method for determining its presence following a negative initial workup. This position paper of the European Society of Cardiology Working Group on e-Cardiology first presents the definition, epidemiology, and clinical impact of cryptogenic ischaemic stroke, as well as its aetiopathogenic association with occult atrial fibrillation. Then, classification methods for ischaemic stroke will be discussed, along with their value in providing meaningful guidance for further diagnostic efforts, given disappointing findings of studies based on the embolic stroke of unknown significance construct. Patient selection criteria for long-term ECG monitoring, crucial for determining pre-test probability of subclinical atrial fibrillation, will also be discussed. Subsequently, the two major classes of long-term ECG monitoring tools (non-invasive and invasive) will be presented, with a discussion of each method's pitfalls and related algorithms to improve diagnostic yield and accuracy. Although novel mobile health (mHealth) devices, including smartphones and smartwatches, have dramatically increased atrial fibrillation detection post ischaemic stroke, the latest evidence appears to favour implantable cardiac monitors as the modality of choice; however, the answer to whether they should constitute the diagnostic choice for cryptogenic stroke patients remains elusive. Finally, institutional and organizational issues, such as reimbursement, responsibility for patient management, data ownership, and handling will be briefly touched upon, despite the fact that guidance remains scarce and widespread clinical application and experience are the most likely sources for definite answers.
隐匿性房颤作为不明原因卒中病因的作用已得到明确确立。长期心电图(ECG)监测仍然是在初始检查结果为阴性后确定其是否存在的唯一方法。欧洲心脏病学会电子心脏病学工作组的这份立场文件首先介绍了隐匿性缺血性卒中的定义、流行病学和临床影响,以及它与隐匿性房颤的病因学关联。然后,将讨论缺血性卒中的分类方法,以及鉴于基于不明原因栓塞性卒中结构的研究结果令人失望,这些方法在为进一步诊断努力提供有意义指导方面的价值。还将讨论长期ECG监测的患者选择标准,这对于确定亚临床房颤的预测试概率至关重要。随后,将介绍两类主要的长期ECG监测工具(非侵入性和侵入性),并讨论每种方法的缺陷以及提高诊断率和准确性的相关算法。尽管包括智能手机和智能手表在内的新型移动健康(mHealth)设备显著提高了缺血性卒中后房颤的检测率,但最新证据似乎支持将植入式心脏监测器作为首选方式;然而,它们是否应成为不明原因卒中患者的诊断选择这一问题仍不明确。最后,尽管指导意见仍然稀缺,广泛的临床应用和经验最有可能是获得明确答案的来源,但仍将简要提及机构和组织问题,如报销、患者管理责任、数据所有权和处理等。